T/SHQAP 001.2-2024 Active Group standards

T/SHQAP 001.2-2024 Guidelines for Continuous Manufacture of Biopharmaceuticals Part 2: Formulations (Therapeutic Proteins)

T/SHQAP 001.2-2024 Guidelines for Continuous Manufacture of Biopharmaceuticals Part 2: Formulations (Therapeutic Proteins)

Publish Date: 2024-04-08 Implement Date: 2024-05-07 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/SHQAP 001.2-2024
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Biological products and blood products
ICS Name: Other standards related to pharmaceutics
Publish Date: 2024-04-08
Implement Date: 2024-05-07

Scope

Main technical content: This document proposes the general principles of continuous manufacturing of protein preparations prepared by engineered cells using continuous manufacturing technology, and suggestions for production management. This document is applicable to the production of protein preparations prepared by engineered cells using continuous manufacturing technology, including the integration of continuous raw materials and preparations, as well as the continuous production process of preparations.

Development Information

Same series standard

Related Standards

Contact Us